Deutsche Bank made a number of updates in a research report published today. NASDAQ OMX (NASDAQ:

) had its rating reiterated at Hold. At the same time, however, its price target was lowered from $30 to $27. On Thursday, NASDAQ lost 2.59% of its value to close the day at $23.35. CBOE Holdings (NASDAQ:

) had its rating reiterated at Hold, while its price target was reduced from $27 to $25. On Thursday, CBOE lost 1.07% of its value to finish the day at $24.11. Fluidigm (NASDAQ:

) had its rating maintained at Buy and its price target reiterated at $20. On Thursday, Fluidigm rose 2.98% to close the day at $14.19. Shire PLC (NASDAQ:

) had its rating maintained at Buy and its price target reiterated at $106. On Thursday, Shire lost 1.12% of its value to finish the day at $90.35. Its shares continued to slide in today's pre-market trading, falling 1.27% to $89.20. H.B. Fuller (NYSE:

) had its rating reiterated at Hold. At the same time, however, its price target was raised from $22 to $24. On Thursday, Fuller surged 7.7% higher to finish the day at $23.64. Its shares retreated slightly in today's pre-market trading, however, falling 0.4% to $23.54. Micron Technology (NASDAQ:

) had its rating reiterated at Hold and its price target lowered from $11 to $9. On Thursday, Micron added 3.18% to its value to close the day at $8.43. Its shares tumbled in today's pre-market trading, however, slumping 12.57% to $7.37. IntercontinentalExchange (NYSE:

) had its rating reiterated at Hold. On Thursday, ICE lost 0.26% to end the day at $119.62. Goldman Sachs (NYSE:

) had its rating reiterated at Buy. On Thursday, Goldman lost 1.61% of its value to finish the day at $132.36. Its shares continued to lose ground in today's pre-market trading, falling 0.35% to $131.90. Morgan Stanley (NYSE:

) had its rating reiterated at Buy. On Thursday, Morgan Stanley lost 1.11% of its value to end the day at $22.35. Its shares recovered slightly in today's pre-market trading, however, rising 0.22% to $22.40. Amedisys Inc (NASDAQ:

) had its rating reiterated at Buy. At the same time, however, its price target was reduced from $42 to $35. On Thursday, Amedisys lost 0.27% of its value to close the day at $25.73. Gentiva Health Services (NASDAQ:

) had its rating maintained at Buy and its price target lowered from $35 to $32. On Thursday, Gentiva lost 1.22% of its value to finish the day at $19.41. LHC Group Inc (NASDAQ:

) had its rating reiterated at Hold. At the same time, however, its price target was lowered to $27 from $34. On Thursday, LHC added 0.71% to its value to end the day at $22.67.